よむ、つかう、まなぶ。
03【資料１】新型コロナワクチンの接種について (50 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_29727.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会（第42回 12／13）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
参考資料一覧（1/5）
2022年秋以降の新型コロナワクチン追加接種及びオミクロン株対応ワクチンの接種に係る諸外国の状況 (1/2)
米国
CDC. 2022. CDC Recommends the First Updated COVID-19 Booster. [online] Available at: <https://www.cdc.gov/media/releases/2022/s0901-covid-19-booster.html> [Accessed 13 Sep 2022].
U.S. Food and Drug Administration. 2022. Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose. [online] Available at: <https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-authorizes-moderna-pfizer-biontech-bivalent-covid-19-vaccines-use> [Accessed 13 Sep 2022].
CDC. 2022. CDC Expands Updated COVID-19 Vaccines to Include Children Ages 5 Through 11. [online] Available at: <https://www.cdc.gov/media/releases/2022/s1012-COVID-19-Vaccines.html> [Accessed 17 Oct 2022].
CDC. 2022. CDC Expands Updated COVID-19 Vaccines to Include Children Ages 6 Months through 5 Years. [online] Available at: <https://www.cdc.gov/media/releases/2022/s1209-covid-vaccine.html> [Accessed 12 Dec 2022].
英国
GOV.UK. 2022. JCVI statement on the COVID-19 booster vaccination programme for autumn 2022: update 3 September 2022. [online] Available at: <https://www.gov.uk/government/publications/covid-19-vaccines-for-autumn-2022-jcviadvice-15-august-2022/jcvi-statement-on-the-covid-19-booster-vaccination-programme-for-autumn-2022-update-15-august-2022> [Accessed Sep 13, 2022].
カナダ
NACI. 2022. Recommendations on the use of bivalent Omicroncontaining mRNA COVID-19 vaccines. [online] Available at:
<https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-bivalent-Omicron-containing-mrna-covid-19vaccines.pdf> [Accessed 13 Sep 2022].
NACI. 2022. Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada. [online] Available at: <https://www.canada.ca/content/dam/phacaspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/naci-guidance-planning-fall-2022-covid-19-vaccine-booster.pdf> [Accessed 13 Sep 2022].
NACI. 2022. Updated guidance on COVID-19 vaccine booster doses in Canada. [online] Available at: <https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committeeon-immunization-naci/guidance-covid-19-vaccine-booster-doses.pdf> [Accessed 17 Oct 2022].
NACI. 2022. Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults. [online] Available at: <https://www.canada.ca/en/publichealth/services/publications/vaccines-immunization/summary-national-advisory-committee-immunization-november-3-2022-recommendations-use-moderna-spikevax-bivalent-mrna-50-mcg-covid-19booster-vaccine-adults.html> [Accessed Dec 2022].
NACI. 2022. Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration. [online] Available at:
<https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/updated-recommendations-use-covid-19-vaccine-boosterdoses-children-5-11-years-concurrent-administration.pdf> [Accessed 12 Dec 2022].
フランス
Ministère des Solidarités et de la Santé. 2022. La campagne de vaccination automnale contre le Covid-19 [online] Available at: < https://solidarites-sante.gouv.fr/grands-dossiers/vaccin-covid-19/article/la-campagnede-vaccination-automnale-contre-le-covid-19 > [Accessed 17 Oct 2022].
HAS. 2022. Stratégie de vaccination contre la Covid-19 : place du vaccin Spikevax bivalent Original / Omicron BA.4/BA.5 (ARNm-1273.222). [online] Available at: <https://www.hassante.fr/jcms/p_3383749/fr/strategie-de-vaccination-contre-la-covid-19-place-du-vaccin-spikevax-bivalent-original-/-omicron-ba-4/ba-5-arnm-1273-222> [Accessed 9 Dec 2022]
50
2022年秋以降の新型コロナワクチン追加接種及びオミクロン株対応ワクチンの接種に係る諸外国の状況 (1/2)
米国
CDC. 2022. CDC Recommends the First Updated COVID-19 Booster. [online] Available at: <https://www.cdc.gov/media/releases/2022/s0901-covid-19-booster.html> [Accessed 13 Sep 2022].
U.S. Food and Drug Administration. 2022. Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose. [online] Available at: <https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-authorizes-moderna-pfizer-biontech-bivalent-covid-19-vaccines-use> [Accessed 13 Sep 2022].
CDC. 2022. CDC Expands Updated COVID-19 Vaccines to Include Children Ages 5 Through 11. [online] Available at: <https://www.cdc.gov/media/releases/2022/s1012-COVID-19-Vaccines.html> [Accessed 17 Oct 2022].
CDC. 2022. CDC Expands Updated COVID-19 Vaccines to Include Children Ages 6 Months through 5 Years. [online] Available at: <https://www.cdc.gov/media/releases/2022/s1209-covid-vaccine.html> [Accessed 12 Dec 2022].
英国
GOV.UK. 2022. JCVI statement on the COVID-19 booster vaccination programme for autumn 2022: update 3 September 2022. [online] Available at: <https://www.gov.uk/government/publications/covid-19-vaccines-for-autumn-2022-jcviadvice-15-august-2022/jcvi-statement-on-the-covid-19-booster-vaccination-programme-for-autumn-2022-update-15-august-2022> [Accessed Sep 13, 2022].
カナダ
NACI. 2022. Recommendations on the use of bivalent Omicroncontaining mRNA COVID-19 vaccines. [online] Available at:
<https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-bivalent-Omicron-containing-mrna-covid-19vaccines.pdf> [Accessed 13 Sep 2022].
NACI. 2022. Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada. [online] Available at: <https://www.canada.ca/content/dam/phacaspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/naci-guidance-planning-fall-2022-covid-19-vaccine-booster.pdf> [Accessed 13 Sep 2022].
NACI. 2022. Updated guidance on COVID-19 vaccine booster doses in Canada. [online] Available at: <https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committeeon-immunization-naci/guidance-covid-19-vaccine-booster-doses.pdf> [Accessed 17 Oct 2022].
NACI. 2022. Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults. [online] Available at: <https://www.canada.ca/en/publichealth/services/publications/vaccines-immunization/summary-national-advisory-committee-immunization-november-3-2022-recommendations-use-moderna-spikevax-bivalent-mrna-50-mcg-covid-19booster-vaccine-adults.html> [Accessed Dec 2022].
NACI. 2022. Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration. [online] Available at:
<https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/updated-recommendations-use-covid-19-vaccine-boosterdoses-children-5-11-years-concurrent-administration.pdf> [Accessed 12 Dec 2022].
フランス
Ministère des Solidarités et de la Santé. 2022. La campagne de vaccination automnale contre le Covid-19 [online] Available at: < https://solidarites-sante.gouv.fr/grands-dossiers/vaccin-covid-19/article/la-campagnede-vaccination-automnale-contre-le-covid-19 > [Accessed 17 Oct 2022].
HAS. 2022. Stratégie de vaccination contre la Covid-19 : place du vaccin Spikevax bivalent Original / Omicron BA.4/BA.5 (ARNm-1273.222). [online] Available at: <https://www.hassante.fr/jcms/p_3383749/fr/strategie-de-vaccination-contre-la-covid-19-place-du-vaccin-spikevax-bivalent-original-/-omicron-ba-4/ba-5-arnm-1273-222> [Accessed 9 Dec 2022]
50